CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for BioSig Technologies Inc is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

BioSig Technologies Inc
55 Greens Farms Road
Phone: (203) 409-5444p:203 409-5444 WESTPORT, CT  06880  United States Ticker: BSGMBSGM
Business Summary
BioSig Technologies, Inc. is a medical device technology company. The Company has an advanced digital signal processing technology platform, the PURE EP Platform (PURE EP), that delivers insights to electrophysiologists for ablation treatments of cardiovascular arrhythmias. PURE EP is designed to address long-standing limitations that slow and disrupt cardiac catheter ablation procedures, such as environmental lab noise from other equipment, signal saturation, slow signal recovery, and inaccurate display of fractionated potentials. PURE EP is a signal processing platform that combines advanced hardware and software to address known challenges associated to signal acquisition, to enable electrophysiologists to see more signals and analyze them in real-time. PURE EP is designed to enhance clinical decision-making and improve clinical workflows for all types of arrhythmias, even the challenging procedures for cardiac arrhythmias, like ventricular tachycardia and atrial fibrillation.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
-Yes-Yes---

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
3/31/202512/31/2024YesYes--Yes

Industries
SIC Code Description
3845 Electromedical and electrotherapeutic apparatus

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chairman of the Board MorganLekstrom 5/28/2025 5/28/2025
Chief Executive Officer, Director HenryMcphie 5/28/2025 5/28/2025
Interim Chief Financial Officer FerdinandGroenewald 40 6/5/2024 6/5/2024
5 additional Officers and Directors records available in full report.

Business Names
Business Name
BSGM
BSGMD
NeuroClear Technologies, Inc.
Streamex Exchange Corporation
ViralClear Pharmaceuticals, Inc. Delaware

General Information
Number of Employees: 5 (As of 4/14/2025)
Outstanding Shares: 136,364,661 (As of 5/28/2025)
Shareholders: 421
Stock Exchange: NASD
Federal Tax Id: 264333375
Fax Number: (302) 645-1280


Copyright © 2025 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Monday, June 9, 2025